• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of clinical psychiatry >Race and long-acting antipsychotic prescription at a community mental health center: A retrospective chart review
【24h】

Race and long-acting antipsychotic prescription at a community mental health center: A retrospective chart review

机译：社区精神卫生中心的种族和长效抗精神病药处方：回顾性图表回顾

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: There has been concern that racial minorities are disproportionately prescribed long-acting injectable antipsychotic drugs. Method: Comprehensive administrative data and clinician survey were used to identify all patients with a DSM-IV diagnosis of schizophrenia who received long-acting antipsychotic prescriptions from July 2009 to June 2010 at a community mental health center. Charts were reviewed retrospectively to validate long-acting antipsychotic prescription (eg, medication, dosage) and merged with administrative data from all center patients documenting sociodemographic characteristics (ie, age, race, gender) and comorbid diagnoses. We used bivariate χ 2, t tests, and multivariate logistic regression to compare the subsample of patients receiving long-acting injectable drugs (n = 102) to patients not receiving long-acting injectable drugs (n = 799) who were diagnosed with schizophrenia for the same period. Results: White patients were significantly less likely to receive long-acting antipsychotic prescriptions than minority patients (OR = 0.52, P .007); ie, nonwhites were 1.89 times more likely to receive such drugs. Age, gender, and comorbid diagnoses, including substance abuse, were unrelated to long-acting injectable prescription, and race/ethnicity was not associated with use of specific agents (haloperidol decanoate, fluphenazine decanoate, or risperidone microspheres) (P = .73). Conclusions: Racial minorities are more likely than other patients with schizophrenia to receive long-acting injectionable antipsychotics, a finding that suggests their prescribers may consider them less adherent to antipsychotic prescriptions.
机译：目的：有人担心少数民族不适当地开了长效抗精神病药物。方法：使用全面的行政数据和临床医生调查来确定2009年7月至2010年6月在社区心理健康中心接受长效抗精神病药处方的所有DSM-IV诊断为精神分裂症的患者。回顾性检查图表以验证长效抗精神病药方剂（例如药物，剂量），并与所有中心患者的行政数据合并，这些数据记录了社会人口统计学特征（即年龄，种族，性别）和合并症。我们使用双变量χ2，t检验和多元logistic回归比较接受长效注射药物治疗的患者（n = 102）与未接受长效注射药物治疗的患者（n = 799）的精神分裂症患者同一时期。结果：与少数患者相比，白人患者接受长效抗精神病药的可能性显着降低（OR = 0.52，P <.007）。也就是说，非白人接受此类药物的可能性高1.89倍。年龄，性别和合并症诊断，包括滥用药物，与长效注射剂无关，种族/种族与特定药物（氟哌啶醇癸酸酯，氟奋乃静癸酸酯或利培酮微球）的使用无关（P = .73） 。结论：种族少数群体比其他精神分裂症患者更可能接受长效注射抗精神病药，这一发现表明他们的处方者可能认为他们对抗精神病药的依从性较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号